Concepedia

Lois Ayash

LA

60

Publications

3K

Citations

29

H-Index

1990

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Wayne State University

The Barbara Ann Karmanos Cancer Institute

University of Michigan

Harvard University

Lois Ayash is an author at Dana-Farber Cancer Institute specializing in medicine, transplantation, and hematology.

ORCID

Top concepts

Publications per year

1990–2021

60

Publications

60

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.

Karen H. Antman, Lois Ayash, Anthony Elias et al. · Journal of Clinical Oncology · 1992 · 374 citations

Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer

AD Elias, Lois Ayash, KC Anderson et al. · Blood · 1992 · 259 citations · Full text

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

Voravit Ratanatharathorn, Lois Ayash, C. Reynolds et al. · Biology of Blood and Marrow Transplantation · 2003 · 199 citations · Full text

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response.

Lois Ayash, J E Wright, Olga Tretyakov et al. · Journal of Clinical Oncology · 1992 · 190 citations

Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study.

Lois Ayash, Anthony Elias, Catherine Wheeler et al. · Journal of Clinical Oncology · 1994 · 141 citations

Rows per page

1–5 of 60